Amanda Meeker, PharmD: Advocating for Community Pharmacists

In this episode of ECAPS Watch, Chair of the Oregon State Pharmacy Association, Amanda Meeker, PharmD, shares her dual perspective from both the payer and advocacy sides of healthcare legislation. She discusses how pharmacists demonstrated their provider capabilities during COVID by testing patients and prescribing Paxlovid, and explains why expanding these services to other conditions like flu and RSV makes sense. Amanda emphasizes the critical importance of gaining more co-sponsors for ECAPS legislation, as leadership won't bring bills to the floor without sufficient support. She also provides key advice for pharmacists preparing for medical billing, stressing the need for correct coding and proper documentation to succeed in this new healthcare delivery model. Learn how to be reimbursement-ready on day 1 for ECAPS at our knowledge hub for pharmacy industry professionals: https://www.workflowservices.com/ecaps

Chapters

• 0:00 Introduction to Amanda Meeker and Her Background
• 1:17 Oregon's Opioid Use Disorder Legislation Experience
• 8:34 Building Legislative Relationships and Expanding Test & Treat
• 10:08 Encouraging Congressional Co-Sponsorship of ECAPS
• 12:30 The Impact of Co-Sponsors on Legislative Success
• 14:49 Medical Billing Tips for ECAPS Implementation
• 17:19 Closing Thoughts and Wrap-Up